106 related articles for article (PubMed ID: 27397134)
21. Cell surface receptor targeted biomimetic apatite nanocrystals for cancer therapy.
Iafisco M; Delgado-Lopez JM; Varoni EM; Tampieri A; Rimondini L; Gomez-Morales J; Prat M
Small; 2013 Nov; 9(22):3834-44. PubMed ID: 23606568
[TBL] [Abstract][Full Text] [Related]
22. The role of carrier ligands of platinum(II) anticancer complexes in the protein recognition of Pt-DNA adducts.
He Y; Yuan J; Qiao Y; Wang D; Chen W; Liu X; Chen H; Guo Z
Chem Commun (Camb); 2015 Sep; 51(74):14064-7. PubMed ID: 26248639
[TBL] [Abstract][Full Text] [Related]
23. Adsorption and spectroscopic characterization of lactoferrin on hydroxyapatite nanocrystals.
Iafisco M; Di Foggia M; Bonora S; Prat M; Roveri N
Dalton Trans; 2011 Jan; 40(4):820-7. PubMed ID: 21152600
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine.
Chen XZ; Ye QS; Lou LG; Xie MJ; Liu WP; Yu Y; Hou SQ
Arch Pharm (Weinheim); 2008 Feb; 341(2):132-6. PubMed ID: 18186542
[TBL] [Abstract][Full Text] [Related]
25. Formulation and in vitro evaluation of polymeric enteric nanoparticles as dermal carriers with pH-dependent targeting potential.
Sahle FF; Balzus B; Gerecke C; Kleuser B; Bodmeier R
Eur J Pharm Sci; 2016 Sep; 92():98-109. PubMed ID: 27393341
[TBL] [Abstract][Full Text] [Related]
26. Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: In vitro and in vivo evaluations.
Jafari S; Maleki-Dizaji N; Barar J; Barzegar-Jalali M; Rameshrad M; Adibkia K
Eur J Pharm Sci; 2016 Aug; 91():225-35. PubMed ID: 27189528
[TBL] [Abstract][Full Text] [Related]
27. Metalated nucleotide chemisorption on hydroxyapatite.
Benedetti M; Antonucci D; De Castro F; Girelli CR; Lelli M; Roveri N; Fanizzi FP
J Inorg Biochem; 2015 Dec; 153():279-283. PubMed ID: 26050880
[TBL] [Abstract][Full Text] [Related]
28. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
[TBL] [Abstract][Full Text] [Related]
29. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
Yu D; Li W; Zhang Y; Zhang B
Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
[TBL] [Abstract][Full Text] [Related]
30. Coordination bonding based pH-responsive albumin nanoparticles for anticancer drug delivery.
Li C; Xing L; Che S
Dalton Trans; 2012 Apr; 41(13):3714-9. PubMed ID: 22370556
[TBL] [Abstract][Full Text] [Related]
31. Oxaliplatin-chitosan nanoparticles induced intrinsic apoptotic signaling pathway: a "smart" drug delivery system to breast cancer cell therapy.
Vivek R; Thangam R; Nipunbabu V; Ponraj T; Kannan S
Int J Biol Macromol; 2014 Apr; 65():289-97. PubMed ID: 24472507
[TBL] [Abstract][Full Text] [Related]
32. Characterization of nano oxaliplatin prepared by novel Fat Employing Supercritical Nano System, the FESNS®.
Lee SJ; Kim YH; Lee SH; Hahn M
Pharm Dev Technol; 2012; 17(2):212-8. PubMed ID: 21073400
[TBL] [Abstract][Full Text] [Related]
33. Smart tetrazole-based antibacterial nanoparticles as multifunctional drug carriers for cancer combination therapy.
Zakerzadeh E; Salehi R; Mahkam M
Drug Dev Ind Pharm; 2017 Dec; 43(12):1963-1977. PubMed ID: 28724328
[TBL] [Abstract][Full Text] [Related]
34. Enhanced cytotoxic activity of bile acid cisplatin derivatives by conjugation with gold nanoparticles.
Sánchez-Paradinas S; Pérez-Andrés M; Almendral-Parra MJ; Rodríguez-Fernández E; Millán A; Palacio F; Orfao A; Criado JJ; Fuentes M
J Inorg Biochem; 2014 Feb; 131():8-11. PubMed ID: 24239907
[TBL] [Abstract][Full Text] [Related]
35. Micellar nanoparticle formation via electrostatic interactions for delivering multinuclear platinum(II) drugs.
Xiao H; Stefanick JF; Jia X; Jing X; Kiziltepe T; Zhang Y; Bilgicer B
Chem Commun (Camb); 2013 May; 49(42):4809-11. PubMed ID: 23595166
[TBL] [Abstract][Full Text] [Related]
36. Encapsulation of anticancer drug copper bis(8-hydroxyquinoline) in hydroxyapatite for pH-sensitive targeted delivery and slow release.
Weerasuriya DRK; Wijesinghe WPSL; Rajapakse RMG
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():206-213. PubMed ID: 27987700
[TBL] [Abstract][Full Text] [Related]
37. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair.
Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA
Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361
[TBL] [Abstract][Full Text] [Related]
38. Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.
Ding Y; Han J; Tian B; Han J; Zhang J; Zheng H; Han Y; Pei M
Int J Pharm; 2014 Dec; 477(1-2):187-96. PubMed ID: 25455771
[TBL] [Abstract][Full Text] [Related]
39. Development of self-assembled nanoceramic carrier construct(s) for vaccine delivery.
Goyal AK; Khatri K; Mishra N; Mehta A; Vaidya B; Tiwari S; Paliwal R; Paliwal S; Vyas SP
J Biomater Appl; 2009 Jul; 24(1):65-84. PubMed ID: 19386666
[TBL] [Abstract][Full Text] [Related]
40. Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition.
Chen D; Lian S; Sun J; Liu Z; Zhao F; Jiang Y; Gao M; Sun K; Liu W; Fu F
Drug Deliv; 2016; 23(3):808-13. PubMed ID: 24892632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
